IndiaTickerLatest filing: Shareholders meeting - Windlas Biotech Limited
ObservedCompany dossier
Windlas Biotech
NSE:WINDLAS · ISIN INE0H5O01029
- Close
- ₹858.55 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Windlas Biotech
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹195 Cr · PAT ₹15.6 Cr.
Exchange XBRLLatest ownership: promoter group 63.31% and public 36.69% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Windlas Biotech Limited: Long-term rating reaffirmed, short term rating upgraded to [ICRA]A1+, rated amount enhanced
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Shareholders meeting - Windlas Biotech Limited
NSE · exchange filing
Observed
Source filing Windlas Biotech Ltd - 543329 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Observed
Source filing Shareholders meeting - Windlas Biotech Limited
NSE · exchange filing
Observed
Source filing Windlas Biotech Ltd - 543329 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹195 Cr
- Profit after tax
- ₹15.6 Cr
- EPS
- ₹7.45
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 63.31%
- Public
- 36.69%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL